Tag: Juno Therapeutics

Bogga Hore / Sanad La Aasaasay

, , , ,

Lisocabtagene maraleucel waxa u ansixisay FDA daawaynta safka labaad ee lymfoma B-cell weyn

Luulyo 2022: Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee bukaanada qaangaarka ah ee qaba lymphoma weyn ee B-cell (LBCL) kuwaas oo qaba cudurka refractory ee chemoi-ka koowaad.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton